Literature DB >> 14662832

Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC.

William L Redmond1, Javier Hernandez, Linda A Sherman.   

Abstract

Activation of naive CD8 T cells in vivo requires the recognition of cognate peptide-MHC complexes on APCs. Depending upon the activation status of the APC, such recognition will promote either a vigorous immune response or T cell tolerance and deletion. Recent studies suggest that the initial signals provided by APCs are sufficient to program the proliferation of naive CD8 T cells and their differentiation into effector cells. In this study, we sought to determine whether an initial encounter with tolerogenic APCs was sufficient to program deletion of naive CD8 T cells. Surprisingly, we find that regardless of whether naive CD8 T cells were stimulated by activated or quiescent APCs, transfer of the activated T cells into an Ag-free host was sufficient to ensure survival. Thus, although the extent of clonal expansion and development of effector function is determined by the activation status of the stimulatory APC, peripheral clonal deletion requires persistent Ag and is not determined by the initial stimulatory event.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662832     DOI: 10.4049/jimmunol.171.12.6349

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Visualization of Cell-Cell Interaction Contacts: Synapses and Kinapses.

Authors:  Michael L Dustin
Journal:  Self Nonself       Date:  2011-04-01

2.  Distinct temporal programming of naive CD4+ T cells for cell division versus TCR-dependent death susceptibility by antigen-presenting macrophages.

Authors:  Adam G Schrum; Ed Palmer; Laurence A Turka
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

3.  Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.

Authors:  Guy Shakhar; Randall L Lindquist; Dimitris Skokos; Diana Dudziak; Julie H Huang; Michel C Nussenzweig; Michael L Dustin
Journal:  Nat Immunol       Date:  2005-05-29       Impact factor: 25.606

4.  Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.

Authors:  Monica V Goldberg; Charles H Maris; Edward L Hipkiss; Andrew S Flies; Lijie Zhen; Rubin M Tuder; Joseph F Grosso; Timothy J Harris; Derese Getnet; Katharine A Whartenby; Dirk G Brockstedt; Thomas W Dubensky; Lieping Chen; Drew M Pardoll; Charles G Drake
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

5.  Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection.

Authors:  Jill M Angelosanto; Shawn D Blackburn; Alison Crawford; E John Wherry
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation.

Authors:  Xiaopei Huang; Yiping Yang
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

7.  Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells.

Authors:  Jason R Lees; Bridget Charbonneau; Axel K Swanson; Robert Jensen; Jianfeng Zhang; Robert Matusik; Timothy L Ratliff
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

8.  A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo.

Authors:  Thomas Fehr; Carrie L Lucas; Josef Kurtz; Takashi Onoe; Guiling Zhao; Timothy Hogan; Casey Vallot; Anjana Rao; Megan Sykes
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

9.  Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity.

Authors:  Anil Shanker; Michel Buferne; Anne-Marie Schmitt-Verhulst
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

10.  Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Authors:  Satoshi Wada; Kiyoshi Yoshimura; Edward L Hipkiss; Tim J Harris; Hung-Rong Yen; Monica V Goldberg; Joseph F Grosso; Derese Getnet; Angelo M Demarzo; George J Netto; Robert Anders; Drew M Pardoll; Charles G Drake
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.